NGM logo

NGM Biopharmaceuticals, Inc. Common Stock

NGM

NGM: NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases. The company's products include NGM282 (aldafermin), NGM313 (MK-3655), NGM120, NGM120, NGM621, and NGM395, all these are focused on NASH, diabetes, oncology, AMD and metabolic disease.

more

Show NGM Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of NGM by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by NGM's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptor Aug. 22, 2023
  • Patent Title: Anti-human beta klotho antibody or binding fragment thereof and methods of their use Jun. 06, 2023
  • Patent Title: Methods of treating nonalcoholic steatohepatitis comprising administering an anti-human beta klotho antibody or binding fragment thereof Mar. 07, 2023
  • Patent Title: Methods of lowering triglyceride levels with an angptl8-binding antibody or antigen-binding fragment thereof Jan. 31, 2023
  • Patent Title: Methods of using compositions comprising variants of fgf19 polypeptides for treating primary biliary cirrhosis in a subject Jan. 31, 2023
  • Patent Title: Methods of treating a wasting syndrome, increasing growth hormone levels, and increasing ghsr activity with a leap2 antibody Jan. 10, 2023
  • Patent Title: Compositions and methods of use for treating metabolic disorders Dec. 20, 2022
  • Patent Title: Methods of treating fibroblast growth factor 19-mediated cancers and tumors Jun. 28, 2022
  • Patent Title: Compositions and methods of use for treating metabolic disorders Jun. 14, 2022
  • Patent Title: Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases Feb. 08, 2022
  • Patent Title: Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders Oct. 12, 2021
  • Patent Title: Anti-c3 antibodies Oct. 05, 2021
  • Patent Title: Methods of using compositions comprising variants of fgf19 polypeptides for reducing bile acid synthesis in a subject having cirrhosis Aug. 31, 2021
  • Patent Title: Compositions comprising variants and fusions of fgf19 polypeptides Jul. 20, 2021
  • Patent Title: Compositions comprising fusion variants of fgf19 polypeptides Jul. 20, 2021
  • Patent Title: Antibodies which bind human glucagon receptor May. 04, 2021
  • Patent Title: Binding proteins and methods of use thereof Apr. 13, 2021
  • Patent Title: Method of treating type i diabetes by administering a combination of a glucagon receptor antagonist and an anti-cd3 antibody Mar. 30, 2021
  • Patent Title: Compositions and methods of use for treating metabolic disorders Dec. 22, 2020
  • Patent Title: Beta klotho-binding proteins Oct. 13, 2020
  • Patent Title: Leap2 binding agents and compositions thereof Sep. 22, 2020
  • Patent Title: Angptl8-binding agents and methods of use thereof Sep. 15, 2020
  • Patent Title: Methods of using compositions comprising variants and fusions of fgf 19 polypeptides for treating diabetes Sep. 01, 2020
  • Patent Title: Beta klotho-binding proteins and methods of use thereof Aug. 18, 2020
  • Patent Title: Methods of using variants of fgf19 polypeptides for the treatment of pruritus Aug. 18, 2020
  • Patent Title: Angiopoietin-like protein 8 polypeptide fragments and compositions thereof Jul. 07, 2020
  • Patent Title: Compositions and methods of use for treating metabolic disorders Feb. 18, 2020
  • Patent Title: Pharmaceutical compositions comprising fgf19 variants Dec. 31, 2019
  • Patent Title: Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases Oct. 29, 2019
  • Patent Title: Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders Oct. 08, 2019
  • Patent Title: Methods of using compositions comprising variants of fgf19 polypeptides for reducing body mass in a subject Sep. 17, 2019
  • Patent Title: Compositions comprising variants of fgf19 polypeptides and uses thereof for the treatment of hyperglycemic conditions Sep. 03, 2019
  • Patent Title: Methods of using variants of fgf19 polypeptides for the treatment of cancer Aug. 06, 2019
  • Patent Title: Compositions and methods of use for treating metabolic disorders Jun. 18, 2019
  • Patent Title: Compositions and methods of use for treating metabolic disorders Feb. 05, 2019
  • Patent Title: Binding proteins and methods of use thereof Jan. 08, 2019
  • Patent Title: Beta-klotho binding proteins Oct. 09, 2018
  • Patent Title: Methods for treatment of conditions associated with elevated triglycerides with an angptl8 polypeptide fragment Sep. 11, 2018
  • Patent Title: Methods of using compositions comprising variants and fusions of fgf19 polypeptides for modulating bile acid homeostasis in a subject having pregnancy intrahepatic cholestasis May. 22, 2018
  • Patent Title: Methods of using compositions comprising variants and fusions of fgf19 polypeptides for reducing glucose levels in a subject May. 08, 2018
  • Patent Title: Methods of using compositions comprising variants and fusions of fgf19 polypeptides for treatment of nonalcoholic steatohepatitis Mar. 27, 2018
  • Patent Title: Compositions and methods of use for treating metabolic disorders Mar. 20, 2018
  • Patent Title: Methods of using compositions comprising variants and fusions of fgf19 polypeptides for modulating bile acid homeostasis in a subject having cholestasis Feb. 20, 2018
  • Patent Title: Methods of using compositions comprising variants and fusions of fgf19 polypeptides for modulating bile acid homeostasis in a subject having nonalcoholic steatohepatitis Feb. 13, 2018
  • Patent Title: Methods of using compositions comprising variants and fusions of fgf19 polypeptides for modulating bile acid homeostasis in a subject having primary sclerosing cholangitis Feb. 13, 2018
  • Patent Title: Methods of using compositions comprising variants and fusions of fgf19 polypeptides for modulating bile acid homeostasis in a subject having error of bile acid synthesis Jan. 30, 2018
  • Patent Title: Methods of using compositions comprising variants and fusions of fgf19 polypeptides for modulating bile acid homeostasis in a subject having bile acid diarrhea or bile acid malabsorption Jan. 30, 2018
  • Patent Title: Compositions and methods of use for treating metabolic disorders Dec. 05, 2017
  • Patent Title: Compositions and methods of use for treating metabolic disorders Nov. 28, 2017
  • Patent Title: Compositions and methods of use for treating metabolic disorders Nov. 28, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of NGM in WallStreetBets Daily Discussion

NGM News

Recent insights relating to NGM

CNBC Recommendations

Recent picks made for NGM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NGM

Corporate Flights

Flights by private jets registered to NGM